卫信康 (603676)
Xizang Weixinkang Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data available
Company NameTibet Weixin Kang Pharmaceutical Co., Ltd.
Listing Date2017-07-21
Issue Price5.53RMB
Registered Capital43516.1510k RMB
Legal RepresentativeZhang Yong
Registered Address3rd Floor, Building 4, Industrial Center, No. 5 Yuannan Road, Zone B, Lhasa Economic and Technological Development Zone, Tibet Autonomous Region
IndustryChemical Pharmaceuticals
Main BusinessGuided by clinical needs, based on R&D innovation, and adhering to the combination of imitation and innovation, the company's main business is the research and development, production, and sales of chemical drug preparations and their active pharmaceutical ingredients. It has strong competitiveness in segments such as intravenous vitamin supplements, intravenous electrolyte supplements, and intravenous iron supplements. It also produces and sells liver-protecting drugs and antibiotic products.
Company ProfileTibet Weixin Kang Pharmaceutical Co., Ltd. was founded in 2006. After years of development, it now has 12 subsidiaries and has become a comprehensive high-tech pharmaceutical enterprise integrating pharmaceutical R&D, production, and sales. Guided by clinical needs, based on R&D innovation, and adhering to the combination of imitation and innovation, the company's main business is the research and development, production, and sales of chemical drug preparations and their active pharmaceutical ingredients. Its core products cover specialized fields such as parenteral nutrition vitamins, electrolyte supplements, intravenous iron supplements, and drugs for digestive system and liver diseases.
Stock Details
1. Key Indicators
- Total Shares(W): 43516.15
- Circulating A-Shares(W): 43516.15
- Earnings Per Share(RMB): 0.5100
- Net Assets Per Share(RMB): 3.5078
- Operating Revenue(W RMB): 86241.68
- Total Profit(W RMB): 26819.30
- **Net Profit Attributable to Parent(W RMB) **: 21917.70
- Net Profit Growth Rate(%): -9.90
- Weighted Return on Equity(%): 15.0100
- Operating Cash Flow Per Share(RMB): 0.2610
- Undistributed Profit Per Share(RMB): 1.5588
- Capital Reserve Per Share(RMB): 0.7989
2. Main Business
The main business covers:
- Research, production, and sales of chemical drug preparations and their active pharmaceutical ingredients
- Intravenous vitamin supplements
- Intravenous electrolyte supplements
- Intravenous iron supplements
- Liver-protecting drugs
- Antibiotic products
3. Company Basic Information
- Company Name: Tibet Weixinkang Pharmaceutical Co., Ltd.
- Listing Date: 2017-07-21
- Industry: Pharmaceutical Manufacturing
- Address: 3rd Floor, Building 4, Industrial Center, No. 5 South Road, Zone B, Lhasa Economic and Technological Development Zone, Tibet Autonomous Region
- Website: http://www.wxkpharma.com
- Company Profile: The company was established by eight shareholders, including Tibet Zhongweikang Investment, through a overall change. On November 24, 2015, Weixinkang Limited held a shareholders' meeting and resolved to convert the company's audited net assets of 391.1447 million yuan as of July 31, 2015, into 200 million shares of the joint-stock company, with a par value of 1 yuan per share. The portion of net assets exceeding the registered capital, 191.1447 million yuan, was recorded as the company's capital reserve. Weixinkang Limited was transformed into a joint-stock company. The capital contributions of the eight founding shareholders during this transformation were verified by Ruihua Certified Public Accountants' Capital Verification Report (Ruihua Yan Zi [2015] No. 01300064) issued on November 24, 2015, and the company obtained the Business License with Unified Social Credit Code 91540091785815591P from the Lhasa Economic and Technological Development Zone Administration for Industry and Commerce on December 2, 2015.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Tibet Weixinkang Enterprise Management Co., Ltd. | General Legal Person | 20524.90 | 47.17 |
| 2 | Tianjin Jingweixinkang Management Consulting Partnership (Limited Partnership) | General Legal Person | 3373.44 | 7.75 |
| 3 | Xiangcai Pharmaceutical Health Hybrid Securities Investment Fund Class A | Fund | 27.10 | 0.06 |
5. Concept Sectors
- Vitamins
- Generic Drugs
Remarks
- Data update date: 2025-10-30
- Data source: Public market information